Preliminary study evaluating the pathogenesis of malignant tumors using 18F-FAPI-74 PET

Preliminary study evaluating the pathogenesis of malignant tumors using 18F-FAPI-74 PET - FAPIONCO1

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051687

Enrollment

120

Registered

2023-07-24

Start date

2023-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

18F-FAPI PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Those who are 18 years of age or older at the time of consent 2. Those who have been diagnosed with or are strongly suspected of having a malignant tumor 3. Those who can give consent for the results of 18F-FAPI-74 PET to be used for medical treatment if deemed necessary by the attending physician 4. Those who can obtain written consent

Exclusion criteria

Exclusion criteria: 1. Those who are or may be pregnant 2. Those who are with severe claustrophobia 3. Those who are considered to be inappropriate to participate in this study by the principal investigator or sub-investigator

Design outcomes

Primary

Measure	Time frame
Uptake difference of 18F-FAPI-74 PET/CT for the organ, lesion, or pathological status	—

Secondary

Measure	Time frame
1. Difference in lesion uptake between 18F-FAPI-74 PET/CT and 18F-FDG PET/CT 2. Relationship between 18F-FAPI-74 PET/CT uptake and specific tumor markers for each malignancy 3. Optimal acquisition time of 18F-FAPI-74 PET/CT	—

Countries

Japan

Contacts

Public ContactTomohiko Yamane

Kobe City Medical Center General Hospital Department of Molecular Imaging Research

tomohiko_yamane@kcho.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026